Clinical Trial Update: Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects [Phase 2]

View source ↗

Summary

Phase 2 pharmacodynamic study evaluating the effect of INCB013739 on insulin sensitivity in obese individuals with type 2 diabetes; the trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• INCB013739

Snippet

Sponsor: Incyte Corporation | Conditions: Diabetes Mellitus, Type 2, Obesity | Phase 2 | Status: COMPLETED